Drug Profile
Research programme: cancer vaccines - ODC Therapy
Alternative Names: ODC-0601; ODC-0801; ODC-0802; ODC-0901Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ODC Therapy
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer in USA (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer in USA (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Lung-cancer in USA (Parenteral, Injection)